Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 20 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
NCT06223542
- Conditions
- Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Indolent Non-hodgkin Lymphoma, +8 more
- Locations
-
- National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
NCT05876923
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Disease Attributes, +15 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT04883437
- Conditions
- Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma, +18 more
- Locations
-
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- Conditions
- Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Follicular Lymphoma, Hemic and Lymphatic Diseases, +16 more
- Locations
-
- Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, North Carolina, United States
NCT03035331
- Conditions
- Aggressive Non-Hodgkin Lymphoma, Chronic Disease, Disease Attributes, +31 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT01231412
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +58 more
- Locations
-
- University of Colorado Denver, Colorado, United States
- Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
- Emory University/Winship Cancer Institute Atlanta, Georgia, United States
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
NCT03105336
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
- University of California Los Angeles Los Angeles, California, United States
- Georgetown Lombardi Comprehensive Cancer Center Washington D.C., District of Columbia, United States
NCT02566304
- Conditions
- Acute Myeloid Leukemia, Acute Myeloid Leukemia in Remission, Anemia, +47 more
- Locations
-
- Thomas Jefferson University Philadelphia, Pennsylvania, United States
NCT04038359
- Conditions
- Indolent Non-hodgkin Lymphoma
- Locations
-
- Florida Cancer Specialists - Fort Myers Fort Myers, Florida, United States
- Florida Cancer Specialists & Research Institute - Lecanto Lecanto, Florida, United States
- Mid-Florida Cancer Centers Orange City, Florida, United States
- Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
NCT01882803
- Conditions
- Indolent Non-hodgkin Lymphoma
- Locations
-
- Los Angeles, California, United States
- Whittier, California, United States
- Denver, Colorado, United States
- Fort Myers, Florida, United States
NCT04136756
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +21 more
- Locations
-
- Western Regional Medical Center - CTCA Goodyear, Arizona, United States
- City of Hope Duarte, California, United States
- University of California, San Francisco San Francisco, California, United States
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
NCT00723099
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +63 more
- Locations
-
- University of Colorado Hospital Aurora, Colorado, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- LDS Hospital Salt Lake City, Utah, United States
- VA Puget Sound Health Care System Seattle, Washington, United States
NCT00075478
- Conditions
- Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Aggressive Non-Hodgkin Lymphoma, +48 more
- Locations
-
- OHSU Cancer Institute-Southern Region Medford, Oregon, United States
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
- LDS Hospital Salt Lake City, Utah, United States
- VA Puget Sound Health Care System Seattle, Washington, United States
NCT01410513
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +19 more
- Locations
-
- Investigational Site Number 840004 Aurora, Colorado, United States
- Investigational Site Number 840006 Augusta, Georgia, United States
- Investigational Site Number 840002 Charleston, South Carolina, United States
Active, Not Recruiting
Glofit and Obin in Follicular Lymphoma and Marginal Zone Lymphoma
NCT05783596
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Columbia University Irving Medical Center New York, United States
- Mount Sinai Medical Center New York, United States
Active, Not Recruiting
Obinutuzumab and Ibrutinib as Front Line Therapy in Treating Patients With Indolent Non-Hodgkin's Lymphomas
NCT03198026
- Conditions
- Ann Abor Stage III B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage II Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Ann Arbor Stage II Follicular Lymphoma, +26 more
- Locations
-
- Sidney Kimmel Cancer Center at Thomas Jefferson University Philadelphia, Pennsylvania, United States
Active, Not Recruiting
Nivolumab With DA-REPOCH Chemotherapy Regimen in Treating Patients With Aggressive B-Cell Non-Hodgkin's Lymphoma
NCT03749018
- Conditions
- Aggressive Non-Hodgkin Lymphoma, Ann Arbor Stage I Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma, Ann Arbor Stage II B-Cell Non-Hodgkin Lymphoma, +22 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Active, Not Recruiting
Parsaclisib Plus the Standard Drug Therapy in Patients With Newly Diagnosed, High Risk Diffuse Large B-cell Lymphoma
NCT04323956
- Conditions
- Ann Arbor Stage II Diffuse Large B-Cell Lymphoma, Ann Arbor Stage II Follicular Lymphoma, Ann Arbor Stage II Marginal Zone Lymphoma, +22 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Active, Not Recruiting
Copanlisib and Nivolumab in Treating Patients With Richter's Transformation or Transformed Indolent Non-Hodgkin Lymphoma
NCT03884998
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, +26 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- OHSU Knight Cancer Institute Portland, Oregon, United States
Active, Not Recruiting
19(T2)28z1xx Chimeric Antigen Receptor (CAR) T Cells in People With B-Cell Cancers
NCT04464200
- Conditions
- Blood Protein Disorders, Burkitt Lymphoma, Burkitt's Lymphoma, +41 more
- Locations
-
- Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Cancer Commack - Suffolk (Limited Protocol Activities) Commack, New York, United States